Einstein Experts

Aging

Ana Maria Cuervo, M.D., Ph.D.

Ana Maria Cuervo, M.D., Ph.D.

Professor, Developmental and Molecular Biology

Professor, Anatomy and Structural Biology

Co-Director, Institute for Aging Research

Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases

Molecular BiologyAgingAutophagy

Cellular biology

Dr. Cuervo is considered a leader in the field of autophagy – the process by which cells recycle their waste. The Barcelona native is also an expert on the molecular biology of aging. Dr. Cuervo has been quoted in numerous publications, including The New York Times and the Scientist. She is co-editor-in-chief of Aging Cell and associate editor of Autophagy and has served on various NIH advisory panels and study sections. Dr. Cuervo’s work focuses on the causes of neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. Her goal is to develop therapies that will restore normal cellular housekeeping and thus prevent the accumulation of toxic protein byproducts and the death of affected cells.
 

Nir Barzilai, M.D.

Nir Barzilai, M.D.

Professor, Medicine (Endocrinology)

Director, Institute for Aging Research

Director, Nathan Shock Center of Excellence in the Basic Biology of Aging

Ingeborg and Ira Leon Rennert Chair of Aging Research

AgingBiology of agingLongevity genes

Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. Dr. Barzilai has been profiled by major outlets, including The New York Times and PBS’ “NOVA scienceNow.” read more...

 

Richard B. Lipton, M.D.

Richard B. Lipton, M.D.

Vice Chair and Professor, Saul R. Korey Department of Neurology, Einstein

Director, Montefiore Headache Center

Director, Einstein Aging Study, Einstein

Edwin S. Lowe Chair in Neurology, Einstein

HeadacheAgingAlzheimer's disease/dementia

MigraineCognitive aging

A noted authority on headaches and migraine, Dr. Lipton is director of the Montefiore Headache Center, recognized internationally for its leadership in the diagnosis, classification and treatment of headache disorders. Dr. Lipton is also director of the Einstein Aging Study, which has been examining both normal brain aging and the special challenges of Alzheimer’s disease and other dementias since 1980.  read more...

 

Jan Vijg, Ph.D.

Jan Vijg, Ph.D.

Professor and Chair, Genetics

Professor, Ophthalmology and Visual Sciences

Lola and Saul Kramer Chair in Molecular Genetics

GeneticsGenomic instabilityAging

Cancer

Dr. Vijg studies the molecular genetic changes associated with aging. Instability of genome and epigenome – the entire set of an organism’s genes and the switches that control their activity –  has long been implicated as the main cause of cancer and of the loss of organ and tissue function associated with aging. read more...

 

Charles B. Hall, Ph.D.

Charles B. Hall, Ph.D.

Professor, Epidemiology & Population Health

Professor, Saul R. Korey Department of Neurology

Alzheimer's disease/dementiaAgingCognition

EpidemiologyBiostatistics

Dr. Hall is a biostatistician recognized for leading important long-term studies of aging and dementia. His research has shown, for example, that brain-stimulating activities delay the onset of dementia. He is the longtime director of the statistical core of the Einstein Aging Study, one of the longest-running prospective studies of aging in the country. He is also the lead statistician for the data coordinating center of the federally funded World Trade Center (WTC) Medical Monitoring & Treatment Program, which provides free health monitoring and treatment for workers and volunteers involved in the rescue, recovery and clean-up activities at the WTC site in New York City.

In his aging studies, Dr. Hall has pioneered the use of change-point models – powerful statistical tools for detecting subtle but meaningful changes in data. He has used these models to show that having more years of formal education or engaging in cognitively stimulating leisure activities appear to protect against developing clinical dementia symptoms. He is also involved in an Einstein study investigating the role of genes in exceptional longevity. read more...